MOMENTA PHARMACEUTICALS INC Payments for Restructuring
MOMENTA PHARMACEUTICALS INC reported Payments for Restructuring of $3.35 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2020-02-27
- MOMENTA PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-12-31 was $197.00K, a 97.25% decline year-over-year.
- MOMENTA PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-09-30 was $873.00K.
- MOMENTA PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-06-30 was $2.26M.
- MOMENTA PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-03-31 was $26.00K.
- MOMENTA PHARMACEUTICALS INC payments for restructuring for fiscal 2019 was $3.35M, a 53.16% decline from fiscal 2018.
- MOMENTA PHARMACEUTICALS INC payments for restructuring for fiscal 2018 was $7.16M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2019-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.07M derived: sum of 2 quarters · filed 2020-02-27 | $3.33M derived: sum of 3 quarters · filed 2020-02-27 | $3.35M 10-K · filed 2020-02-27 |
| 2019-09-30 | $873.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $3.13M derived: sum of 2 quarters · filed 2019-11-04 | $3.15M 10-Q · filed 2019-11-04 | $10.31M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.28M 10-Q · filed 2019-08-07 | $9.44M derived: sum of 3 quarters · filed 2020-02-27 | $9.44M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $26.00K 10-Q · filed 2019-05-03 | $7.18M derived: sum of 2 quarters · filed 2020-02-27 | $7.18M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2018-12-31 | $7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.16M derived: sum of 2 quarters · filed 2020-02-27 | $7.16M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 |